- Funding period:
-
01.11.2021 - 31.10.2024
- Project description:
-
The project will combine high-throughput experiments, bioinformatics analysis and mathematical modeling to derive a molecular understanding of CART19 therapy resistance. This will derive prognostic biomarkers and targets of combination therapy.
Project coordination
![This image shows Stefan Legewie](https://www.srcsb.uni-stuttgart.de/img/210421-_ProfLegewie_06.jpg?__scale=w:150,h:150,cx:0,cy:0,cw:220,ch:220)
Stefan Legewie
Prof. Dr.Member of the SRCSB Board of Directors